ESC Premium Access

The SIRT1 activator resveratrol ameliorates dystrophic cardiomyopathy by promoting mitophagy.

Presentation

About the speaker

Associate Professor Atsushi Kuno

Sapporo Medical University, Second Dept. of Internal Medicine, Sapporo (Japan)
1 presentation
0 follower

5 more presentations in this session

CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

Speaker: Doctor N. Raad (New York, US)

Thumbnail

Impaired Excitation Contraction Coupling in Human Induced Pluripotent Stem Cell Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation

Speaker: Doctor K. Hammer (Regensburg, DE)

Thumbnail

Arrhythmogenic Cardiomyopathy type 8 zebrafish models: opportunities for the identification of early pathogenetic events and new therapeutic targets

Speaker: Associate Professor N. Tiso (Padua, IT)

Thumbnail

BNP signal peptide protects the heart from ischemia-reperfusion injury

Speaker: Professor C. Pemberton (Christchurch, NZ)

Thumbnail

Mutations contributing to clonal hematopoiesis are associated with poor prognosis in chronic ischemic heart failure

Speaker: Professor B. Assmus (Giessen, DE)

Thumbnail

Access the full session

Late Breaking Basic and Translational Science - Cardiac Biology

Speakers: Associate Professor A. Kuno, Doctor N. Raad, Doctor K. Hammer, Associate Professor N. Tiso, Professor C. Pemberton...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk